SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is currently trending amidst heightened retail interest and a surging community dialogue about its potential for a significant breakout. Despite some historical underperformance, traders are keenly observing technical indicators and anticipating a major rally, with many viewing current price levels as a critical opportunity before an expected upward move.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA is generating significant buzz, primarily driven by its extremely low public float and high insider ownership, fueling speculation among traders about a potential short squeeze. The community is actively comparing its recent volatility and rapid price movements to other trending SPACs, with discussions often focusing on its merger agreement and aggressive upside potential.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions is trending following a recent manufacturing partnership announcement, which has intensified short-squeeze activity driven by its extremely low public float after a recent reverse stock split. The community is actively discussing the stock's significant volatility and potential for further upward momentum, contrasting with some calls for caution. This market dynamic unfolds as the company expands global adoption of its non-invasive fingerprint drug screening technology and navigates the FDA clearance process for the U.S. market.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending with high enthusiasm following its FDA approval for NEREUS, marking the first new motion sickness treatment in over four decades. The community is actively discussing the drug's game-changing potential, particularly its ability to address GLP-1 induced nausea, which presents a vast market opportunity and fuels speculation of a major pharma buyout. This significant regulatory win, alongside VNDA's robust pipeline and strong financial position, is driving widespread bullish sentiment.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is trending after the FDA issued a Complete Response Letter for its relacorilant hypertension indication, triggering a sharp stock decline and intense community debate. Investors are divided, with many viewing the sell-off as an overreaction given the company's existing profitable drug and other pipeline programs, while others express caution regarding potential delays and future prospects.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is generating significant buzz following substantial insider share purchases by Apple CEO and Nike board member Tim Cook and its own CEO, Elliott Hill, signaling strong executive confidence. This activity has sparked a lively debate among investors, with many viewing it as a compelling turnaround story and value opportunity after recent market pressure, while some remain cautious about ongoing challenges and competitive headwinds.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

Ondas Holdings is trending after announcing significant new orders for its autonomous systems, bolstering its position in critical defense and infrastructure sectors. The community is expressing strong optimism, amplified by this robust demand and the recent launch of a 2X leveraged ETF, which has increased market visibility. Investors are actively discussing Ondas's expanding leadership in the multi-domain autonomy space, driven by global security needs and strategic growth.

Alchemy Investments Acquisition Corp. 1 is a blank check company, which engages in merger, share exchange, asset acquisition, share purchase, and reorganization or similar business combination. The company was founded on October 27, 2021 and is headquartered in Newark, DE.

Alchemy Investments Acquisition Corp 1 - Ordinary Shares - Class A

ALCY is capturing significant attention amid a broader "low float SPAC" trend, drawing parallels to recent high-volume movements in similar vehicles. Community sentiment is highly optimistic, anticipating a breakout fueled by its limited share availability and a recent announcement regarding a potential merger with Cartiga, a litigation finance asset management platform. Traders are actively discussing rotational plays and expecting substantial momentum as part of this ongoing SPAC theme.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending due to the FDA granting Priority Review for its AXS-05 treatment for Alzheimer's disease agitation, with an action date anticipated in April, alongside positive updates for its narcolepsy candidate, AXS-12. This pivotal regulatory progress, coupled with strong sales growth for its existing Auvelity product, is driving significant community excitement, as investors anticipate continued pipeline advancements and a potential transition to a higher market valuation. Many believe the company is "killing it" and poised for substantial future gains, celebrating consistent product performance and strategic momentum in the CNS therapeutic space.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending amidst renewed optimism following China's confirmation of extended EV trade-in subsidies into 2026 and its CEO's upbeat Q4 outlook, which anticipates record deliveries and potential profitability. This positive context is met with fervent community debate, as many investors decry perceived market manipulation suppressing the stock despite improving fundamentals and expanding battery swap infrastructure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gladstone Investment Corporation (NASDAQ:GAIN) Receives Consensus Rating of "Hold" from Analysts

Shares of Gladstone Investment Corporation (NASDAQ:GAIN - Get Free Report) have been assigned a consensus rating of "Hold" from the five analysts that are currently covering the company, MarketBeat...

Gladstone Investment (NASDAQ:GAIN) Stock Price Passes Above 200-Day Moving Average - Should You Sell?

Gladstone Investment (NASDAQ:GAIN) Share Price Passes Above 200-Day Moving Average - Here's What Happened...

Gladstone Investment Corporation (NASDAQ:GAIN) Receives Average Rating of "Hold" from Brokerages

Gladstone Investment Corporation (NASDAQ:GAIN - Get Free Report) has received an average recommendation of "Hold" from the five research firms that are currently covering the company, MarketBeat...

Virtus Investment Advisers LLC Sells 33,003 Shares of Gladstone Investment Corporation $GAIN

Virtus Investment Advisers LLC lowered its holdings in shares of Gladstone Investment Corporation (NASDAQ:GAIN - Free Report) by 38.0% during the second quarter, according to the company in its most...

Gladstone Investment (NASDAQ:GAIN) Lowered to Hold Rating by Zacks Research

Zacks Research cut shares of Gladstone Investment from a "strong-buy" rating to a "hold" rating in a report on Tuesday...

Gladstone Investment Corporation (NASDAQ:GAIN) Given Average Rating of "Moderate Buy" by Analysts

Gladstone Investment Corporation (NASDAQ:GAIN - Get Free Report) has received an average recommendation of "Moderate Buy" from the five brokerages that are covering the firm, Marketbeat reports...

Gladstone Investment (GAIN) Meets Q2 Earnings Estimates

Gladstone Investment (GAIN) delivered earnings and revenue surprises of 0.00% and +1.89%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Gladstone Investment (GAIN) Reports Q1 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Gladstone Investment (GAIN) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Gladstone Investment (GAIN) Q1 Earnings Beat Estimates

Gladstone Investment (GAIN) delivered earnings and revenue surprises of +4.35% and -1.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

PennantPark (PNNT) Q3 Earnings Meet Estimates

PennantPark (PNNT) delivered earnings and revenue surprises of 0.00% and -0.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Gladstone Investment Corp., a traded business development company, which engages in the provision of lower middle market companies located in the United States. The fund focuses on companies with an EBITDA of USD 4 - 15 million. It targets companies operating in the fields of manufacturing, consumer products and business and consumer services. It provides financing for debt, buyout and growth stage capital requirements with an investment size up to USD 75 million. The company was founded in 2005 and is headquartered in McLean, VA.

GAIN
Gladstone Investment Corporation

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GAIN News

GAINGladstone Investment Corporation